Public Hearings

 

2025 annual public hearing on prescription drug prices

Dec. 4, 2024 Hearing

Agenda

Highlights and recommendations from the 2025 Drug Price Transparency Report

• Agency presentation of the 2025 Drug Price Transparency Report to the Oregon Legislature

Biologics and biosimilars – interchangeability and adoption

• Invited presenters to speak about biosimilars and their marketing and similarity to the original biologic treatment.

Innovative prescription financing solutions

• Invited presenters to speak about challenges and ideas for financing drugs that create issues for traditional insurance financing models.

There will be opportunities for public comment. Interim Insurance Commissioner TK Keen will facilitate the hearing, and Oregon legislators will ask questions and lead discussions about the panel presentations.

Public testimony

We encourage you to testify at the hearing or provide written testimony. Contact us at rx.prices@dcbs.oregon.gov for any questions you have about sharing your story or the public hearing.

Share your stories

The Oregon Department of Consumer and Business Services is asking for the public's help before the 2025 public hearing on prescription drug prices. The department has set up a brief survey for consumers to share their stories about rising prescription drug prices. Drug prices play a major role in the health care decisions of Oregonians, and the cost of prescription drugs have steadily increased. The department wants to hear your stories about the increased costs of prescription drug prices and how they have affected you and your family.